Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0112 Elderly AML 8/1/2001 4/1/2003 100% Published
    Closed S0114 EGFRvIII Peptide Vaccine 11/1/2002 6/1/2006 47%
    Closed S0115 Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study 1/1/2004 10/15/2010 95% Published
    Closed S0116 D1/3-MAGE-3 His Protein + SB-AS02B/Selected Stage IV, M1a or M1b 9/15/2002 2/15/2004 2%
    Closed S0117 Phase II Mylotarg™ for Relapsed AML 4/1/2003 10/15/2005 60%
    Closed S0119 Gemcitabine/Irinotecan Untreated Extensive SCLC 1/1/2002 2/15/2003 100% Published
    Closed S0120 Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders 6/1/2002 4/1/2011 97% Published
    Closed S0121 Local Bladder 11/15/2002 6/1/2005 9%
    Closed S0122 Cisplat/Etopo/RT followed by Cisplat/Etopo/TriAb & TriGem Vaccines in Limited SCLC 12/15/2002 5/15/2003 10%
    Closed S0124 Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC 11/1/2002 3/1/2007 99% Published
    Closed S0125 Phase II Elderly AML in First Complete Remission 4/1/2003 6/1/2005 10%
    Closed S0126 ZD1839/BAC/Previously-Untreated & Previously-Treated; Selected IIIB & IV 12/1/2001 7/1/2003 100% Published
    Closed S0127 GASTRIC AND GE JUNCTION 6/1/2002 8/15/2003 88% Published
    Closed S0200 OVARIAN 8/15/2002 12/15/2004 6% Published
    Closed S0202 GALLBLADDER AND CHOLANGIOCARCINOMA 9/1/2003 4/1/2005 100% Published
    Closed S0204 Newly Diagnosed Multiple Myeloma Tandem Transplant 6/15/2002 10/15/2005 100% Published
    Closed S0205 PANCREATIC 1/1/2004 4/1/2006 100% Published
    Closed S0207 Testicular 4/1/2002 3/1/2005 50% Published
    Closed S0211 Ovarian 4/15/2002 1/1/2006 77% Published
    Closed S0213 Mantle Cell Lymphoma 10/1/2002 9/1/2006 100% Published
    Scroll Table